CAL-T constructs and uses thereof

RECOMBINANT VECTOR CARRYING DISULFIDE BOND ISOMERASE SIGNAL PEPTIDE AND USE THEREOF

Materials and methods for engineering cells and uses thereof in immuno-oncology

PLAP-CAR-effector cells

CARTYRIN COMPOSITIONS AND METHODS FOR USE

Constructs specifically recognizing glypican 3 and uses thereof

Anti-CD20 antibody and uses thereof

Cells expressing chimeric activating receptors and chimeric stimulating receptors and uses thereof

Methods and compositions for genetically modifying lymphocytes to express polypeptides comprising the intracellular domain of MPL

VACCINE COMPOSITIONS AND METHODS FOR ENHANCED ANTIGEN-SPECIFIC VACCINATION

NK-92 Bone and Brain targeting

METHODS FOR IMPROVING ADOPTIVE CELL THERAPY

METHODS FOR PREPARING CELLS FOR ADOPTIVE T CELL THERAPY

CHIMERIC RECEPTORS AND METHODS OF USE THEREOF

Chimeric antibody/T-cell receptor constructs and uses thereof

Humanized anti-GDNF family alpha-receptor 4 (GRF-alpha-4) antibodies and chimeric antigen receptors (CARs)

Cell comprising a chimeric antigen receptor or a transgenic T-cell receptor and comprising a chimeric TNF receptor

COMPOSITIONS AND METHODS OF PHOSPHOLIPASE A2 RECEPTOR CHIMERIC AUTOANTIBODY RECEPTOR T CELLS

Therapeutic agents

METHODS AND COMPOSITIONS FOR TREATMENT OF HEMOPHILIA

NUCLEIC ACID CONSTRUCTS COMPRISING GENE EDITING MULTI-SITES AND USES THEREOF

CHIMERIC ANTIGEN RECEPTORS AGAINST SENESCENT CELLS AND USES THEREOF

REGULATABLE CHIMERIC ANTIGEN RECEPTOR

Chimeric TIM4 receptors and uses thereof

Materials and methods for engineering cells and uses thereof in immuno-oncology

Compositions comprising polypeptides having xylanase activity and polypeptides having arabinofuranosidase activity

Reducing immune tolerance induced by PD-L1

CD19-CD20 BISPECIFIC AND DUAL PASSWAY CAR-T AND METHODS FOR USE THEREOF

COMPOSITIONS AND METHODS FOR DELIVERY AND EXPRESSION OF SMALL INHIBITORY PEPTIDES AND USE THEREOF

Universal donor cells

HLA-G AS A NOVEL TARGET FOR CAR T-CELL IMMUNOTHERAPY

Immune cells engineered to express CD19-directed chimeric antigen receptors and uses thereof in immunotherapy

CD19-directed chimeric antigen receptors and uses thereof in immunotherapy

Anti-CCT5 binding molecules and chimeric antigen receptors comprising the same

Universal donor cells

Universal donor cells

Universal donor cells

Peptide-MHC compacts

Pooling signaling and costimulatory domains in B7H6 chimeric antigen receptor

Multi-chain chimeric polypeptides and uses thereof

Multi-chain chimeric polypeptides and uses thereof

Universal donor cells

METHODS AND COMPOSITIONS OF CYTOTOXIC T CELL DEPLETION

CA2 compositions and methods for tunable regulation

Synthetic notch receptor protein for modulating gene expression

Chimeric antigen receptors and methods of use thereof

Modified N-810 and Methods Therefor

Cancer immunotherapy using CD19-directed chimeric antigen receptors

Methods and compositions for treating cancer

Enhanced immune cells using dual shRNA and composition including the same

Adhesion Receptor Constructs and Uses Thereof in Natural Killer Cell Immunotherapy

IMMUNE CELLS EXPRESSING A CHIMERIC ANTIGEN RECEPTOR

Modulation of SLAMF6 splice variants for cancer therapy

CAR T CELL THERAPIES WITH ENHANCED EFFICACY

DNase therapy for intravascular accumulation of extracellular DNA

Human alpha-folate receptor chimeric antigen receptor

SYSTEM AND METHODS RELATING TO CHIMERIC AUTOANTIBODY RECEPTORS

ENGINEERED VEGF VARIANTS FOR RETINAL NEUROPROTECTION, PROMOTION OF AXON GROWTH AND AXON REGENERATION

Molecular switch-mediated control of engineered cells

CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF

Expression of phytase in

Compositions for Treating Ectopic Calcification Disorders, and Methods Using Same

Methods of treating T cell exhaustion by inhibiting or modulating T cell receptor signaling

CD83-BINDING CHIMERIC ANTIGEN RECEPTORS

POLYPEPTIDES AND METHODS

APOM-FC FUSION PROTEINS AND USES THEREOF

SINGLE-CHAIN CD40-RECEPTOR AGONIST PROTEINS

METHOD FOR SECRETORY PRODUCTION OF PROTEIN

MODULATING T CELL FUNCTION AND RESPONSE

Target recognition motifs and uses thereof

NKG2D CHIMERIC ANTIGEN RECEPTORS

EXPRESSION VECTORS FOR CHIMERIC ENGULFMENT RECEPTORS, GENETICALLY MODIFIED HOST CELLS, AND USES THEREOF

CHIMERIC TIM-3 FUSION PROTEIN

Cellular immunotherapy compositions and uses thereof

Polypeptides having xylanase activity and polynucleotides encoding same

Constructs trageting CD22 and uses thereof

ANTI-CD33 CHIMERIC ANTIGEN RECEPTORS AND THEIR USES

Neutralization of Human Cytokines with Membrane-Bound Anti-Cytokine Non-Signaling Binders Expressed in Immune Cells

METHODS OF PRODUCING CELLS EXPRESSING A RECOMBINANT RECEPTOR AND RELATED COMPOSITIONS

CELLULAR SIGNALING DOMAIN ENGINEERING IN CHIMERIC ANTIGEN RECEPTOR-MODIFIED REGULATORY T CELLS

Polypeptides comprising a modified bacteriophage G3P amino acid sequence lacking a glycosylation signal

Chimeric inhibitor molecules of complement activation

Compositions and methods for T cell delivery of therapeutic molecules

LONG-ACTING IGF-1 OR IGF-1 VARIANTS AND METHODS OF PRODUCING SAME

NOVEL HUMANIZED ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR, ITS NUCELIC ACID SEQUENCE AND ITS PREPARATION

Transgene genetic tags and methods of use

COMPOSITIONS AND METHODS FOR TREATING PARKINSON'S DISEASE

Trophoblast glycoprotein (5T4, TPBG) specific chimeric antigen receptors for cancer immunotherapy

Human mesothelin chimeric antigen receptors and uses thereof

ANTI CD30 CHIMERIC ANTIGEN RECEPTOR AND ITS USE

GENETICALLY MODIFIED CELLS AND METHOD FOR PRODUCING SAME

PD-1 and PD-L1 binding agents

Exosomes for immuno-oncology and anti-inflammatory therapy

COMPOSITIONS AND METHODS FOR INHIBITION OF ALPHAVIRUS INFECTION

Materials and methods for engineering cells and uses thereof in immuno-oncology

Materials and methods for engineering cells and uses thereof in immuno-oncology

OPTIMIZED LENTIVIRAL TRANSFER VECTORS AND USES THEREOF

DNase therapy for intravascular accumulation of extracellular DNA

IL-33 SECRETING IMMUNORESPONSIVE CELLS AND USES THEREOF

Dimeric antigen receptors

Humanized BCMA antibody and BCMA-CAR-T cells

CAR-T CELLS AND AUTOIMMUNE DISEASES

IMPROVED T CELL COMPOSITIONS AND METHODS

Compositions and methods for treating cancer with DuoCARs

Recombinant human replication-deficient adenovirus comprising a modified nucleic acid encoding the Marburg virus envelope glycoprotein

Filovirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same

COMPOSITIONS TO DISRUPT PROTEIN KINASE A ANCHORING AND USES THEREOF

EXPRESSION AND SECRETION SYSTEM

Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy

LAMP constructs

ELIMINATION OF CD19-POSITIVE LYMPHOID MALIGNANCIES BY CD19-CAR EXPRESSING NK CELLS

Targeting B cell activating factor receptor (BAFF-R) using ligand-based chimeric antigen receptor (CAR)-T cells

Ligand discovery and gene delivery via retroviral surface display

Engineered Expression of Cell Surface and Secreted Sialidase by CAR T Cells for Increased Efficacy in Solid Tumors

CELLULAR BASED THERAPIES TARGETING DISEASE-ASSOCIATED MOLECULAR MEDIATORS OF FIBROTIC, INFLAMMATORY AND AUTOIMMUNE CONDITIONS

T-cell modulatory multimeric polypeptide with conjugation sites and methods of use thereof

Single-chain TNF receptor 2 agonist fusion proteins

DOMINANT NEGATIVE LIGAND CHIMERIC ANTIGEN RECEPTOR SYSTEMS

Chimeric peptides with an antimicrobial domain and an inorganic binding domain

Methods for preparing modified von Willebrand factor

Compositions and methods for TCR reprogramming using fusion proteins

BCMA-targeted chimeric antigen receptor as well as preparation method therefor and application thereof

Method of redirecting t cells to treat HIV infection

Compositions and methods for TCR reprogramming using fusion proteins

Modified immune cells and uses thereof

XCR1 BINDING AGENTS AND USES THEREOF

ANTI-CANCER DNA VACCINE EMPLOYING PLASMIDS ENCODING SIGNAL SEQUENCE, MUTANT ONCOPROTEIN ANTIGEN, AND HEAT SHOCK PROTEIN

Regulatory T cell expressing a chimeric antigen receptor

USE AND PRODUCTION OF ENGINEERED IMMUNE CELLS TO DISRUPT NFAT-AP1 PATHWAY TRANSCRIPTION FACTORS

TISSUE FACTOR-TARGETING CAR-NK AND CAR-T CELL THERAPY

Engineered DNase enzymes and use in therapy

Activation of APC in immunotherapy

METHODS FOR ENHANCING AND MAINTAINING CAR-T CELL EFFICACY

USES OF AMPHIPHILES IN IMMUNE CELL THERAPY AND COMPOSITIONS THEREFOR

Compositions and methods for targeting CLEC12A-expressing cancers

Prostate-specific membrane antigen cars and methods of use thereof

Engineered phagocytic receptor compositions and methods of use thereof

Engineered phagocytic receptor compositions and methods of use thereof

Protease-resistant systems for polypeptide display and methods of making and using thereof

Compositions and methods for selective protein degradation

Compositions and methods for targeting γδ T cells with chimeric antigen receptors

Reducing immune inhibition induced by SIGLEC-15

Promoter polynucleotide, signal polypeptide and use thereof

CHIMERIC ANTIGEN RECEPTOR (CAR) SIGNALLING SYSTEM

Materials and methods for the synthesis of error-minimized nucleic acid molecules

Force sensor cleavage domain containing chimeric polypeptides and methods of use thereof

Therapeutic agents

SINGLE-CHAIN LIGHT RECEPTOR AGONIST PROTEINS

Fusion proteins and combination vaccines comprising Protein E and Pilin A

Materials and methods for engineering cells and uses thereof in immuno-oncology

METHODS AND COMPOSITIONS RELATING TO ENGINEERED REGULATORY T CELLS

NOVEL CHIMERIC ANTIGEN RECEPTORS AND LIBRARIES

Methods of treatments using antigen-binding proteins targeting CD56

Methods and compositions for improved expression of recombinant proteins

Recombinant Protein

ENGINEERED CELLS FOR ADOPTIVE CELL THERAPY

Anti-CD70 chimeric antigen receptors

Enhanced chimeric antigen receptors and uses thereof

Methods and compositions for treating and preventing HIV

Chimeric engulfment receptor molecules and methods of use

Chimeric antigen receptors targeted to PSCA

Thymic stromal lymphopoietin receptor-specific chimeric antigen receptors and methods using same

CTLA-4 variant immunomodulatory proteins and uses thereof

Chimeric Natural Killer Cell Receptors and Method of Using Thereof

Chimeric antigen receptor (CAR) modulation

COMPOSITIONS AND METHODS FOR TARGETED TUMOR IMMUNOTHERAPY

PRIMARY CELL GENE EDITING

CDKL5 EXPRESSION VARIANTS AND CDKL5 FUSION PROTEINS

ROR1 antibody compositions and related methods

Immunoassays and engineered proteins for monitoring antibody treatments to the immune checkpoint inhibitors PD1 and PD-L1

Cell

Compositions comprising polypeptides having xylanase activity and polypeptides having arabinofuranosidase activity

Cell secreted minibodies and uses thereof

Chimeric antigen receptors, compositions, and methods

Compositions and methods for immunomodulation in an organism

Constitutively active chimeric cytokine receptors

Genetically engineered vaccinia viruses

Targeted protein degradation

Anti-HLA-A2 antibodies, related chimeric antigen receptors, and uses thereof

Anti-hla-A2 antibodies and methods of using the same

M971 chimeric antigen receptors

VARIANT ICOS LIGAND IMMUNOMODULATORY PROTEINS AND RELATED COMPOSITIONS AND METHODS

Therapeutic agents

Compositions and methods for inhibition of lineage specific antigens

Nucleic acid molecules encoding chimeric antigen receptors targeting B-cell maturation antigen and uses thereof

Methods of using chimeric antigen receptors targeting B-cell maturation antigen and uses thereof

Compositions and methods for improved T cells

Compositions and methods for treating cancer

Rationally-designed synthetic peptide shuttle agents for delivering polypeptide cargos from an extracellular space to the cytosol and/or nucleus of a target eukaryotic cell, uses thereof, methods and kits relating to same

GAMMA DELTA T CELLS AND USES THEREOF

METHODS AND COMPOSITIONS FOR ALLEVIATING CYTOKINE RELEASE SYNDROME

CD33 exon 2 deficient donor stem cells for use with CD33 targeting agents

Universal platform for preparing an inhibitory chimeric antigen receptor (iCAR)

Influenza virus-like particle production in plants

Antibody chemically induced dimerizer (AbCID) as molecular switches for regulating cellular therapies

Cell

PROTEIN SECRETORY FACTOR WITH HIGH SECRETORY EFFICIENCY AND AN EXPRESSION VECTOR COMPRISING THE SAME

Chimeric Antigen Receptor

Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof

Chimeric antigen receptors targeting abnormal glycobiology

Headless hemagglutin influenza vaccine

Human cytomegalovirus RNA vaccines

Method of reducing mesothelin-expressing tumor burden by administration of T cells comprising mesothelin-targeted chimeric antigen receptors

MODIFIED EPIDERMAL GROWTH FACTOR RECEPTOR PEPTIDES FOR USE IN GENETICALLY-MODIFIED CELLS

CYCLIC GALANIN-ANALOGS AND USES THEREOF

Cancer treatment

T-cells expressing anti-LIV1 chimeric antigen receptor

GPRC5D chimeric antigen receptors and cells expressing the same

CD8 binding agents

Compositions and methods for treating cancer with anti-mesothelin immunotherapy

Compositions and methods for treating cancer with DuoCARs

Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells

MGAT1-Deficient Cells for Production of Vaccines and Biopharmaceutical Products

Modular polypeptide libraries and methods of making and using same

Compositions and methods for targeting CD33-expressing cancers

Chimeric antigen receptors (CARs), compositions and methods thereof

Recombinant PETase producing strain, recombinant MHETase producing strain, and composition for degrading PET containing the same

Integral membrane protein display on poxvirus extracellular enveloped virions

Chimeric antigen receptors and CAR-T cells that bind CXCR5 and methods of use thereof to treat medical disorders

Chimeric antigen receptors with enhanced NFκB signaling

Compositions and methods for modulating immune cells

TREATMENT OF CANCER USING A CLL-1 CHIMERIC ANTIGEN RECEPTOR

Modified urokinase-type plasminogen activator polypeptides and methods of use

T CELLS EXPRESSING A CHIMERIC ANTIGEN RECEPTOR

COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS

Selectively controllable cleavable linkers

CELL COMPRISING A CHIMERIC ANTIGEN RECEPTOR (CAR)

Mutant tumor necrosis factor receptor superfamily (TNFsfR) ligands and methods of making and using same

BAFF-R antibodies and uses thereof

Nanonets and spherical particles

DNA vaccine against virus of Yellow Fever

Primary cell gene editing

Methods and compositions for secretion of heterologous polypeptides

Chimeric transcription factor variants with augmented sensitivity to drug ligand induction of transgene expression in mammalian cells

OCTS technology-based pancreatic cancer and malignant mesothelioma CAR-T therapeutic vector, construction method therefor, and use thereof

Malignant glioma CAR-T therapeutic vector based on OCTS technology, and construction method and application thereof

ANTIBODY-COUPLED T CELL RECEPTOR CONSTRUCTS AND THERAPEUTIC USES THEREOF

Nsp-interleukin-10 proteins and uses thereof

Fusion proteins for inhibiting angiogenesis

Modified cell with enhanced migration capability

Immunologic effector cell of targeted CLD18A2, and preparation method and use thereof

Primary cell gene editing

CD123-binding chimeric antigen receptors

HLA-DR CAR-T COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME

Rapid elicitation of broadly neutralizing antibodies to HIV Env

Compositions and methods of use for treating metabolic disorders

Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancer

Methods of producing aggregate-free monomeric diphtheria toxin fusion proteins and therapeutic uses

Compositions and methods for treating cancer with anti-CD22 immunotherapy

Modified cell expressing therapeutic agent and uses thereof

METHODS AND COMPOSITION FOR SECRETION OF HETEROLOGOUS POLYPEPTIDES

HLA-restricted VCX/Y peptides and T cell receptors and use thereof

COMPOSITIONS AND METHOD FOR IDENTIFYING ENZYME AND TRANSPORT PROTEIN INHIBITORS

Anti-PTK7 immune cell cancer therapy

PROTEASE BASED SWITCH CHIMERIC ANTIGEN RECEPTORS FOR SAFER CELL IMMUNOTHERAPY

Universal non-classical MHC I vaccines: HLA-E-restricted antigenic peptides as universal vaccines to treat allergy, inflammation, autoimmune and infectious diseases, and cancers

Non-natural NKG2D receptors that do not directly signal the cells to which they are attached

Targeting modules for universal chimeric antigen receptor expressing immune cells and use in the treatment of cancer infections and autoimmune disorders

Truncated NKG2D chimeric receptors and uses thereof in natural killer cell immunotherapy

Proteins and peptide tags with enhanced rate of spontaneous isopeptide bond formation and uses thereof

Herpes simplex virus vaccine

EHRLICHIA RUMINANTIUM IMMUNOGENIC COMPOSITIONS AND METHODS OF USING THEREOF

Chimeric antigen receptors with mutated CD28 costimulatory domains

Elimination of CD19-positive lymphoid malignancies by CD19-CAR expressing NK cells

Chimeric antibody immune effector cell engagers and methods of use thereof

Monoclonal antibody targeting a unique sialoglycosylated cancer-associated epitope of CD43

Compositions and methods for treating cancer with anti-CD19 immunotherapy

Methods of exogenous drug activation of chemical-induced signaling complexes expressed in engineered cells in vitro and in vivo

Virulence attenuated bacteria based protein delivery

COMPOSITIONS AND METHODS FOR ADOPTIVE CELL THERAPIES

CHIMERIC RECEPTORS AND METHODS OF USE THEREOF

Cells expressing chimeric activating receptors and chimeric stimulating receptors and uses thereof

Methods and compositions for increasing red blood cells

Articles of manufacture and methods related to toxicity associated with cell therapy

Methods of making T cell compositions

Compositions and methods for treating cancer with anti-CD19/CD20 immunotherapy

CHIMERIC ANTIGEN RECEPTORS (CAR) AND METHODS FOR MAKING AND USING THE SAME

Methods and compositions for treating and preventing HIV

PDE5 compositions and methods for immunotherapy

Anti-CD30 antibodies and methods for treating CD30+ cancer

Methods and systems to produce lignin-modifying enzymes and uses thereof

Process for the purification of recombinant antibody fragments

THERAPEUTIC CELLS

Targeted chimeric proteins and uses thereof

Chimeric antigen receptor cells targeting ROBO1, preparation method and use thereof

Compositions and methods for treating cancer with anti-CD19/CD22 immunotherapy

BIOMARKERS AND CAR T CELL THERAPIES WITH ENHANCED EFFICACY

HUMAN APPLICATION OF ENGINEERED CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELLS

Immune cells expressing engineered antigen receptors

CRISPR-Cas9 Knock-out of SHP-1/2 to Reduce T cell Exhaustion in Adoptive Cell Therapy

Compositions and methods for targeting stromal cells for the treatment of cancer

BCMA chimeric antigen receptors

Chimeric antigen receptors and methods of use

METHODS FOR DETERMINING CAR-T CELLS DOSING

Chimeric antigen receptors targeting BCMA and methods of use thereof

Targeted engineered interferon and uses thereof

CAR T therapy through uses of co-stimulation

Multi-chain chimeric polypeptides and uses thereof

Synthetic protein circuits detecting signal transducer activity

Targeted disruption of the MHC cell receptor